0001604689-17-000004.txt : 20170510
0001604689-17-000004.hdr.sgml : 20170510
20170510164419
ACCESSION NUMBER: 0001604689-17-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170503
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001457612
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 510596811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-876-8191
MAIL ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poole Jonathan
CENTRAL INDEX KEY: 0001604689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 17831102
MAIL ADDRESS:
STREET 1: C/O GENOCEA BIOSCIENCES, INC.
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
wf-form4_149444904447921.xml
FORM 4
X0306
4
2017-05-03
0
0001457612
GENOCEA BIOSCIENCES, INC.
GNCA
0001604689
Poole Jonathan
C/O GENOCEA BIOSCIENCES, INC.
100 ACORN PARK DRIVE, 5TH FLOOR
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Common Stock
2017-05-03
4
A
0
7937
0
A
25150
D
Common Stock
2017-05-03
4
A
0
23810
0
A
48960
D
Common Stock
2017-05-08
4
S
0
6213
6.51
D
42747
D
Common Stock
2017-05-10
4
F
0
3500
6.13
D
39247
D
The restricted stock units ("RSUs") were granted in accordance with Genocea Biosciences, Inc.'s (the "Company") 2014 Equity Incentive Plan (the "Plan") and vested immediately upon grant.
The RSUs were granted in accordance with the Plan and will vest in full 18 months from the grant date, subject to Mr. Poole's continued employment with the Company.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Shares sold to cover taxes on RSUs that vested on May 3, 2017.
/s/ Jonathan Poole
2017-05-10